Answers are grounded in this paper and cite their sources.
The genus Trichoderma contains more 100 species which are used as bioprotectants for the management of a number of fungal and plant pathogens by virtue of their broad-spectrum action. The present study focuses to evaluate four Trichoderma isolates (CA-03, CA-06, CA-07 and CA-08) ability to produce volatile and non-volatile metabolites against Fusarium oxysporum f. sp. capsici (FOC) and Colletotrichum capsici (CC) by using inverse plate technique and poisoned food technique which enables the identification of secondary metabolites from culture filtrate and mycelial mass of potential Trichoderma isolates through GC/MS analysis. Furthermore, molecular property and bioactivity score of those secondary metabolites were predicted using molinspiration software. Studies indicated that volatile metabolites from Trichoderma isolate code CA-07 (26.2% and 40.9%) was found to be most effective in reducing the mycelial growth followed by CA-06 isolate (22.0% and 31.9%) of FOC and CC, respectively. However, non-volatile compounds from Trichoderma isolate code CA-07, followed by CA-06 were effectively inhibiting mycelial growth of tested pathogens at 5%, 10% and 15% concentration. GC-MS analysis was carried out in order to identify active secondary metabolites of potential Trichoderma isolates CA-07 and CA-06. A total of 19 and 15 peaks were identified for CA-07 and CA-06, respectively. These compounds are mainly carboxylic acid and fatty acid esters. Among 34 compounds, 12 compounds followed Lipinski's rule of five and can also act as a good binder towards few receptors. 1 H-Indene-1,5(6H)-dione, 2, 3, 7, 7a -tetrahydro-7a-methyl-(0.53) was found to have lowest log P value which indicates its good drug likeness score also, it showed highest score towards enzyme inhibitor (0.32) which exhibited antibiotic nature and also used as a drug for treatment of dermatological disorder. Thus, it can be further considered for in vivo study for management of FOC and CC.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: